Background Carriers of multidrug-resistant bacteria are at risk of infections with these
bacteria; the precise size of this risk is unclear. We aimed to quantify the effect of gut …

Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infections,
accounting for significant disease burden and mortality. The clinical spectrum of C. difficile …

Humans and other mammalian hosts have evolved mechanisms to control the bacteria
colonizing their mucosal barriers to prevent invasion. While the breach of barriers by …

In recent years, an increase in invasive VRE infections has been reported worldwide,
including Germany. The most common gene encoding resistance to glycopeptides is VanA …

Therapies in oncology have evolved rapidly over the last years. At the same pace,
supportive care for patients receiving cancer therapy has also evolved, allowing patients to …

Abstract Background Vancomycin-resistance in Enterococcus faecium (VRE) poses a major
threat in health care settings. It is well known that patients in hematology and oncology …

Background Vancomycin-resistant enterococci (VRE) are major therapeutic challenges.
Prospective contemporary data characterizing the clinical and molecular epidemiology of …

Enterococcus faecium is a difficult-to-treat pathogen with emerging resistance to most
clinically available antibiotics. Daptomycin (DAP) is the standard of care, but even high DAP …

Enterococci are commensals of human and other animals' gastrointestinal tracts. Only
making up a small part of the microbiota, they have not played a significant role in research …

BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a
curative treatment option for patients with acute myeloid leukemia (AML). During …